von Delft, Annette http://orcid.org/0000-0002-7699-8140
Hall, Matthew D. http://orcid.org/0000-0002-5073-442X
Kwong, Ann D.
Purcell, Lisa A. http://orcid.org/0000-0002-9565-2030
Saikatendu, Kumar Singh
Schmitz, Uli
Tallarico, John A.
Lee, Alpha A.
Article History
Accepted: 4 April 2023
First Online: 12 May 2023
Competing interests
: All authors and/or their employers are involved in COVID drug discovery or development programmes, and may continue to be involved in future programmes. These programmes may lead to the generation of intellectual property for their respective employers, and may directly or indirectly contribute to past, present or future revenue of their respective employers. M.D.H. is an employee of NCATS, A.K. is an employee of Pardes Biosciences, L.A.P. is an employee of Vir Biotechnology, K.S.S. is an employee of Takeda California, Inc., U.S. is an employee of Gilead Sciences, J.A.T. is an employee of Novartis Institutes for Biomedical Research, A.v.D. is an employee of Oxford University, and consults for PostEra, Inc. A.A.L. is an employee of Cambridge University and CSO for PostEra, Inc.
Free to read: This content has been made available to all.